Organization | Mercy Health Partners, Cincinnati

Mercy Health Partners, Cincinnati Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Cincinnati Ohio United States (1986)

Organization Overview

First Clinical Trial

2014

NCT02267044

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Cincinnati Sportsmedicine and Orthopaedic Center | Mercy Health | Mercy Health Ohio

Active Ingredients

Drugs in Phase 4 Trials (11)

ampicillin (1 trial)

cefazolin (ancef) (1 trial)

ceftriaxone (rocephin) (1 trial)

chlorhexidine (hibitane) (1 trial)

clindamycin (cleocin) (1 trial)

fentanyl (Innovar) (1 trial)

gentamicin (garamycin) (1 trial)

ketamine (ketalar) (1 trial)

piperacillin (pipracil) (1 trial)

sulbactam (unasyn) (1 trial)

tazobactam (Zosyn) (1 trial)

Drugs in Phase 3 Trials (2)

diphenhydramine (benadryl) (1 trial)

droperidol (innovar) (1 trial)

Drugs in Phase 2 Trials (1)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Other Trials (2)

methylprednisolone (medrol) (1 trial)

ropivacaine (naropin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acne Vulgaris (Phase 4)

Acute Pain (Phase 4)

Emergencies (Phase 2)

Epistaxis (Phase 2)

Fractures, Bone (Phase 4)

Fractures, Open (Phase 4)

Surgical Wound Infection (Phase 4)

Wound Infection (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 16